Centessa Pharmaceuticals plc reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported net loss was USD 36.84 million compared to USD 43.17 million a year ago. Basic loss per share from continuing operations was USD 0.38.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.48 USD | +3.49% | +0.21% | +19.10% |
Apr. 24 | Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Wednesday Amid Earnings Deluge | MT |
Apr. 24 | Centessa Pharmaceuticals Prices Equity Offering at $9.25 Per ADS | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.10% | 1.05B | |
+0.67% | 42.4B | |
+46.73% | 40.04B | |
-6.20% | 28.31B | |
+6.55% | 24.94B | |
-21.66% | 18.96B | |
+29.96% | 12.3B | |
-1.57% | 11.95B | |
+16.03% | 11.32B | |
-4.80% | 11.55B |
- Stock Market
- Equities
- CNTA Stock
- News Centessa Pharmaceuticals plc
- Centessa Pharmaceuticals plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2023